Delivery Order SPE2DB25D3012-SPE2DB25FXAEP
Award Date 9/17/25
Potential Completion Date 10/8/25
Potential Value $70K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for the supply of Orserdu 345 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was issued on September 16, 2025, with an ultimate completion date of October 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. The delivery order operates as a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $27,841.82 by the Defense Logistics Agency's Medical Supply Chain for the supply of Orserdu 345 mg tablets (30-count packaging). The contract is a non-set-aside, competitively awarded delivery order with firm fixed pricing, scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for Orserdu 345 mg tablets (30-count units) on August 29, 2025, with an ultimate completion date of September 22, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Orserdu 345 mg tablets in quantities of 30 units. This $13,920.91 firm fixed price delivery order, which is scheduled for completion by September 10, 2025, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $13,920.91 to AmerisourceBergen Drug Corp for 30-count tablets of Orserdu 345 mg, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 22, 2025, for Orserdu 345 mg tablets (30-count supply) with a ceiling value of $13,920.91. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award. The contract is performed at the vendor's Corporate Office location in Conshohocken, PA and supports the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Orserdu (orsethamine) 345 mg tablets in a 30-count package under a firm fixed-price contract with a ceiling value of $13,920.91. The award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive delivery order issued without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for ORSERDU 345 mg tablets in a 30-count package configuration. This firm fixed-price delivery order, valued at $27,841.82, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. The delivery order was competitively awarded...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $41,762.73 for ORSERDU 345 mg tablets (30-count units) from the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. The contract represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 29, 2025. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...